119 related articles for article (PubMed ID: 38190799)
1. Reduction in Breast Cancer Death With Adjuvant Chemotherapy Among US Women According to Race, Ethnicity, and the 21-Gene Recurrence Score.
Huang HC; Calip GS; Weiss J; Simons Y; Gadi VK; Danciu OC; Rauscher GH; Hoskins KF
J Natl Compr Canc Netw; 2024 Jan; 22(1D):e237077. PubMed ID: 38190799
[TBL] [Abstract][Full Text] [Related]
2. Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women.
Hoskins KF; Danciu OC; Ko NY; Calip GS
JAMA Oncol; 2021 Mar; 7(3):370-378. PubMed ID: 33475714
[TBL] [Abstract][Full Text] [Related]
3. Racial/ethnic differences in the utilization of chemotherapy among stage I-III breast cancer patients, stratified by subtype: Findings from ten National Program of Cancer Registries states.
Zhang L; King J; Wu XC; Hsieh MC; Chen VW; Yu Q; Fontham E; Loch M; Pollack LA; Ferguson T
Cancer Epidemiol; 2019 Feb; 58():1-7. PubMed ID: 30415099
[TBL] [Abstract][Full Text] [Related]
4. Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia.
Collin LJ; Yan M; Jiang R; Ward KC; Crawford B; Torres MA; Gogineni K; Subhedar PD; Puvanesarajah S; Gaudet MM; McCullough LE
NPJ Breast Cancer; 2019; 5():32. PubMed ID: 31583272
[TBL] [Abstract][Full Text] [Related]
5. Racial/ethnicity disparities in invasive breast cancer among younger and older women: An analysis using multiple measures of population health.
Hung MC; Ekwueme DU; Rim SH; White A
Cancer Epidemiol; 2016 Dec; 45():112-118. PubMed ID: 27792934
[TBL] [Abstract][Full Text] [Related]
6. Racial and ethnic disparities in 21-gene recurrence scores, chemotherapy, and survival among women with hormone receptor-positive, node-negative breast cancer.
Han Y; Miao ZF; Lian M; Peterson LL; Colditz GA; Liu Y
Breast Cancer Res Treat; 2020 Dec; 184(3):915-925. PubMed ID: 32929567
[TBL] [Abstract][Full Text] [Related]
7. Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
Bassett MT; Chen JT; Krieger N
PLoS Med; 2020 Oct; 17(10):e1003402. PubMed ID: 33079941
[TBL] [Abstract][Full Text] [Related]
8. Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
Albain KS; Gray RJ; Makower DF; Faghih A; Hayes DF; Geyer CE; Dees EC; Goetz MP; Olson JA; Lively T; Badve SS; Saphner TJ; Wagner LI; Whelan TJ; Ellis MJ; Wood WC; Keane MM; Gomez HL; Reddy PS; Goggins TF; Mayer IA; Brufsky AM; Toppmeyer DL; Kaklamani VG; Berenberg JL; Abrams J; Sledge GW; Sparano JA
J Natl Cancer Inst; 2021 Apr; 113(4):390-399. PubMed ID: 32986828
[TBL] [Abstract][Full Text] [Related]
9. Oncotype DX Risk Recurrence Score and Total Mortality for Early-Stage Breast Cancer by Race/Ethnicity.
Moore J; Wang F; Pal T; Reid S; Cai H; Bailey CE; Zheng W; Lipworth L; Shu XO
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):821-830. PubMed ID: 35064066
[TBL] [Abstract][Full Text] [Related]
10. Racial Differences in Time to Breast Cancer Surgery and Overall Survival in the US Military Health System.
Eaglehouse YL; Georg MW; Shriver CD; Zhu K
JAMA Surg; 2019 Mar; 154(3):e185113. PubMed ID: 30673075
[TBL] [Abstract][Full Text] [Related]
11. Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy.
Woriax HE; Thomas SM; Plichta JK; Rosenberger LH; Botty van den Bruele A; Chiba A; Hwang ES; DiNome ML
J Clin Oncol; 2024 May; 42(14):1635-1645. PubMed ID: 38394476
[TBL] [Abstract][Full Text] [Related]
12. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer.
Carbajal-Ochoa WH; Johnson D; Alvarez A; Bernal AM; Anampa JD
Breast Cancer Res Treat; 2023 Sep; 201(2):275-287. PubMed ID: 37442877
[TBL] [Abstract][Full Text] [Related]
14. Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region.
Davis Lynn BC; Chernyavskiy P; Gierach GL; Rosenberg PS
J Natl Cancer Inst; 2022 Feb; 114(2):263-270. PubMed ID: 34508608
[TBL] [Abstract][Full Text] [Related]
15. Lack of racial differences in clinical outcomes of breast cancer patients receiving neoadjuvant chemotherapy: a single academic center study.
Sarma M; Perimbeti S; Nasir S; Attwood K; Kapoor A; O'Connor T; Early A; Levine EG; Takabe K; Kalinski P; Ambrosone C; Khoury T; Yao S; Gandhi S
Breast Cancer Res Treat; 2022 Apr; 192(2):411-421. PubMed ID: 35000093
[TBL] [Abstract][Full Text] [Related]
16. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results.
Press DJ; Ibraheem A; Dolan ME; Goss KH; Conzen S; Huo D
Breast Cancer Res Treat; 2018 Feb; 168(1):207-220. PubMed ID: 29181717
[TBL] [Abstract][Full Text] [Related]
17. Racial Disparities in Survival Outcomes of Patients With Serous Epithelial Ovarian Cancer: A Retrospective Cohort Analysis.
Shingala K; Stavros S; Parag S; Tercek A; Makhani SS; Bouz A; Galbo A; Chung-Bridges K
Cureus; 2023 Jan; 15(1):e34389. PubMed ID: 36874646
[TBL] [Abstract][Full Text] [Related]
18. Survival difference between non-Hispanic black and non-Hispanic white women with localized breast cancer: the impact of guideline-concordant therapy.
Wu X; Richardson LC; Kahn AR; Fulton JP; Cress RD; Shen T; Wolf HJ; Bolick-Aldrich S; Chen VW
J Natl Med Assoc; 2008 May; 100(5):490-8. PubMed ID: 18507201
[TBL] [Abstract][Full Text] [Related]
19. Racial and Ethnic Disparities in Lung Adenocarcinoma Survival: A Competing-Risk Model.
Wu X; Wang Y; Lin X; Wang Z; Xu J; Lv W; Hu J
Clin Lung Cancer; 2020 May; 21(3):e171-e181. PubMed ID: 31787547
[TBL] [Abstract][Full Text] [Related]
20. Patient Characteristics at Prostate Cancer Diagnosis in Different Races at an Academic Center Serving a Diverse Population.
Suresh T; Sharma J; Goel S; Kovac E; Gao Q; Gartrell B
Clin Genitourin Cancer; 2019 Apr; 17(2):139-144. PubMed ID: 30655076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
